Journals / Türk Patoloji Dergisi / 2014 / Cilt: 30 - Sayı: 3

TTF-1 Beyin Tümörlerini Metastazdan Ayırmada Güvenilir Bir Belirteç Olmayabilir

TTF-1 may not be a Reliable Marker for Differentiating Metastasis from Brain Tumors

Pages
201–205
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Clinical and pathological parameters should be evaluated together.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: TTF-1 is widely used as an immunohistochemical marker of lung and thyroid tumors.
📊
Key Findings & Data:However, TTF-1 expression has been described in tumors from other sites.
💡
Conclusion & Impact:Clinical and pathological parameters should be evaluated together.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: TTF-1 is widely used as an immunohistochemical marker of lung and thyroid tumors. However, TTF-1 expression has been described in tumors from other sites. The presence of TTF-1 expression in primary brain tumors is largely unclear and has not been clearly specified yet. We characterized expression of two TTF-1 clones in primary brain tumors with relevance to tumor types and grades. Material and Method: We studied immunohistochemistry with tissue micro-array, using both clones (8G7G3/1 and SPT24) in 45 primary brain tumors of different types and grades. Our cases consisted of 1 grade I, 7 grade II, 4 grade III, 20 grade IV astrocytic tumors; 9 meningiomas, 2 oligodendrogliomas, 1 schwannoma and 1 medulloblastoma. Results: We have found TTF-1 nuclear staining using the SPT24 clone in 4 cases (3 cases were grade IV and 1 was grade III). Focal and weak staining was seen in three cases and moderate-strong and diffuse staining was seen in one case. All the tumors were negative with clone 8G7G3/1. Clone SPT24 was more sensitive but less specific. Conclusion: TTF-1 can also be expressed in primary brain tumors, particularly grade III to IV tumors. TTF-1 expression was a rare finding in previous studies, however strong and diffuse staining was not observed until today. We think that TTF-1 nuclear expression in high-grade astrocytic tumors cannot rule out primaries even when diffuse and strong staining. Clinical and pathological parameters should be evaluated together.

Özet

Amaç: TTF-1 akciğer ve tiroid tümörleri için yaygın kullanılan immünohistokimyasal bir belirteçtir. Ayrıca diğer bölgelerin tümörlerinde de TTF-1 ekspresyonu tanımlanmıştır. Ancak primer beyin tümörlerinde TTF-1 ekspresyonu varlığı belirsiz ve net olarak ifade edilmemiştir. Biz primer beyin tümörlerinde tümör tipi ve derecesi ile karşılaştırmalı olarak TTF-1in iki klonuna ait ekspresyonu araştırdık. Gereç ve Yöntem: Farklı tip ve derecelerde 45 primer beyin tümöründe doku mikro array yöntemi kullanarak her iki TTF-1 klonu (8G7G3/1 ve SPT24) çalışıldı. Olgularımız; astrositik tümör derece I (1 olgu), derece II (7 olgu), derece III (4 olgu), derece IV (20 olgu) ve 9 meninjiom, 2 oligodendrogliom, 1 schwannom ve 1 medülloblastomdan oluşmaktaydı. Bulgular: SPT-24 klonunu kullanarak 4 olguda (3 olgu derece 4 ve 1 olgu derece 3) nükleer TTF-1 boyanması bulduk. Üç olgu fokal ve zayıf boyanma, 1 olgu ise orta-şiddetli ve diffüz boyanma şeklinde idi. Tüm tümörler 8G7G3/1 klonu ile negatif idi. SPT24 klonu daha sensitif ama az spesifiktir. Sonuç: TTF-1 özellikle derece 3 ve 4 olmak üzere primer beyin tü- mörlerinde eksprese olabilir. TTF-1 ekspresyonu geçmiş çalışmalarda nadir izlenen bir bulgu olup, şiddetli ve diffüz boyanma günümüze kadar hiç bildirilmemiştir. Yüksek dereceli astrositik tümörlerde TTF-1 nükleer ekspresyonu, boyanma kuvvetli ve diffüz olsa bile pri- meri dışlayamaz düşüncesindeyiz. Ayırıcı tanı için klinik ve patolojik parametreler birlikte değerlendirilmelidir.

🔖

Cite This Article

ÜNAL, B., YILDIRIM, Ş., SEZER, C., SÜREN, D. (2022). TTF-1 Beyin Tümörlerini Metastazdan Ayırmada Güvenilir Bir Belirteç Olmayabilir. Türk Patoloji Dergisi, Cilt: 30 - Sayı: 3, 201–205. https://ajindex.com/articles/640605

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Boggaram V. Thyroid transcription factor-1 (TTF-1/Nkx2.1/ TITF1) gene regulation in the lung. Clin Sci (Lond). 2009;116:27- 35
  2. Ikeda K, Clark JC, Shaw-White JR, Stahlman MT, Boutell CJ, Whitsett JA. Gene structure and expression of human thyroid transcription factor-1 in respiratory epithelial cells. J Biol Chem. 1995;270:8108-14
  3. Civitareale D, Castelli MP, Falasca P, Saiardi A. Thyroid transcription factor 1 activates the promoter of the thyrotropin receptor gene. Mol Endocrinol. 1993;7:1589-95
  4. Nóbrega-Pereira S, Kessaris N, Du T, Kimura S, Anderson SA, Marín O. Postmitotic Nkx2-1 controls the migration of telencephalic interneurons by direct repression of guidance receptors. Neuron. 2008;59:733-45
  5. Kristensen MH, Nielsen S, Vyberg M. Thyroid transcription factor-1 in primary CNS tumors. Appl Immunohistochem Mol Morphol. 2011;19:437-43
  6. Matoso A, Resnick MB, Wang LJ. Comparison of 2 monoclonal TTF-1 antibodies. Appl Immunohistochem Mol Morphol. 2011;19:384
  7. Dettmer M, Kim TE, Jung CK, Jung ES, Lee KY, Kang CS. Thyroid transcription factor-1 expression in colorectal adenocarcinomas. Pathol Res Pract. 2011;207:686-90
  8. Bisceglia M, Galliani C, Rosai J. TTF-1 expression in breast carcinoma-the chosen clone matters. Am J Surg Pathol. 2011;35:1087-8
  9. Robens J, Goldstein L, Gown AM, Schnitt SJ. Thyroid transcription factor-1 expression in breast carcinomas. Am J Surg Pathol. 2010;34:1881-5
  10. Compérat E, Zhang F, Perrotin C, Molina T, Magdeleinat P, Marmey B, Régnard JF, Audouin J, Camilleri-Broët S. Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin. Mod Pathol. 2005;18: 1371-6
  11. Penman D, Downie I, Roberts F. Positive immunostaining for thyroid transcription factor-1 in primary and metastatic colonic adenocarcinoma: A note of caution. J Clin Pathol. 2006;59: 663-4
  12. Zamecnik J, Chanova M, Kodet R. Expression of thyroid transcription factor 1 in primary brain tumours. J Clin Pathol. 2004;57:1111-3
  13. Prok AL, Prayson RA. Thyroid transcription factor-1 staining is useful in identifying brain metastases of pulmonary origin. Ann Diagn Pathol. 2006;10:67-71
  14. Galloway M, Sim R. TTF-1 staining in glioblastoma multiforme. Virchows Arch. 2007;451:109-11
  15. Lee EB, Tihan T, Scheithauer BW, Zhang PJ, Gonatas NK. Thyroid transcription factor 1 expression in sellar tumors: A histogenetic marker? J Neuropathol Exp Neurol. 2009;68:482-8
  16. Lazzaro D, Price M, de Felic